Quick Answer
Zenas BioPharma, Inc. reported Shares Outstanding of 54.49 million shares for fiscal year 2025.
Zenas BioPharma, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 54.49M | +30.4% |
| 2024 | 41.79M | +2550.4% |
| 2023 | 1.58M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 42.21M | +1.0% | +0.3% |
| June 30, 2025 | 42.09M | — | +0.6% |
| March 31, 2025 | 41.82M | — | +0.1% |
| December 31, 2024 | 41.79M | +2550.4% | +0.0% |
| September 30, 2024 | 41.78M | — | +2549.6% |
| December 31, 2023 | 1.58M | — | — |
- Zenas BioPharma, Inc. showed an increase of +30.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2023–2025 period, Zenas BioPharma, Inc.’s shares outstanding has grown by 3355.3% (from 1.58 million shares to 54.49 million shares).
- The most recent figure is from Zenas BioPharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: